DMK
MRNS

David M. Knott’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

David M. Knott’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$924K Hold
81,166
– – 0.34% 59
2021
Q2 		$1.46M Buy
81,166
+20,900
+35% +$336K 0.52% 46
2021
Q1 		$933K Buy
60,266
+35,266
+141% +$510K 0.4% 55
2020
Q4 		$305K Buy
+25,000
New +$349K 0.14% 69

Other funds holding MRNS

LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

David M. Knott's MRNS Position: Q3 2021 in Review

David M. Knott held its Marinus Pharmaceuticals, Inc (MRNS) position steady in Q3 2021 at 81,166 shares worth $924K. The position accounts for 0.34% of the portfolio, ranked #59.

David M. Knott first reported a position in MRNS in Q4 2020 and has held it in 4 quarters since. The position peaked at $1.46M in Q2 2021. 82 funds tracked by Wall St. Rank hold MRNS as of Q3 2021.

  • David M. Knott held 81,166 shares of Marinus Pharmaceuticals, Inc worth $924K as of Q3 2021.
  • David M. Knott left its Marinus Pharmaceuticals, Inc share count unchanged in Q3 2021.
  • Marinus Pharmaceuticals, Inc made up 0.34% of David M. Knott's portfolio in Q3 2021, its #59 holding.
  • David M. Knott first reported a position in Marinus Pharmaceuticals, Inc in Q4 2020 and has held it in 4 quarters since.
  • David M. Knott's Marinus Pharmaceuticals, Inc position peaked at $1.46M in Q2 2021.
  • 82 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.